MedTrace Logo

Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates

NCT06206590 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 116

Last updated 2024-01-16

No results posted yet for this study

Summary

1\. Explore 32 weeks of premature infants or maternal pregnancy infection of newborn septic shock maternal influence factors. 2. Through maternal blood samples before delivery and labor cord blood sample screening and septic shock related proteomics analysis, explore the relationship between the difference protein and septic shock and prognosis, and explore the pathway mechanism, in order to prevent and reduce the occurrence of septic shock in premature infants

Conditions

  • Neonatal Disease

Interventions

OTHER

Whole-proteomic assay

Whole-proteomic analysis was performed on all the blood samples

Sponsors & Collaborators

  • Guangdong Women and Children Hospital

    lead OTHER

Principal Investigators

  • xiuzhen ye · Guangdong Women and Children Hospital

Eligibility

Min Age
1 Day
Max Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2025-09-01
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06206590 on ClinicalTrials.gov